Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2014Archives of Disease in Childhood

Safety of medicines used for ADHD in children: a review of published prospective clinical trials

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAntonio ClavennaMario Negri Institute for Pharmacological ResearchMBMaurizio BonatiMario Negri Institute for Pharmacological Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clavenna et al. (2014) studied this question.

synapsesocial.com/papers/6a1c4b3501af05bf0da92d9fhttps://doi.org/10.1136/archdischild-2013-304170
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder2001 · 508 citations
  2. 2A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/Hyperactivity Disorder2002 · 181 citations
  3. 3Reducing overdiagnosis and disease mongering in ADHD in Lombardy2013 · 20 citations
  4. 4Low quality of reporting adverse drug reactions in paediatric randomised controlled trials2010 · 56 citations
  5. 5Observational, nonintervention, multicenter study for validation of the bowel function index for constipation in european countries2010 · 53 citations